Log In
Print this Print this

Cell Cultured Influenza vaccine (BLB-750)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionCell culture-based pandemic influenza vaccine (H5N1 and prototype)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Cellular vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsPrevent pandemic influenza
Regulatory Designation Japan - Orphan Drug (Prevent pandemic influenza)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today